Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis. (2022)

First Author: Tallantyre EC
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.msard.2022.103937

PubMed Identifier: 35700625

Publication URI: http://europepmc.org/abstract/MED/35700625

Type: Journal Article/Review

Volume: 64

Parent Publication: Multiple sclerosis and related disorders

ISSN: 2211-0348